Michael Kotsanis
Directeur Général chez ACRUX LIMITED
Profil
Michael John Kotsanis is currently the Chief Executive Officer, Director & MD at Acrux Ltd.
and a Director at AI Lamb (NZ) Ltd.
He previously worked as an Independent Non-Executive Director at Idt Australia Ltd., Chief Commercial Officer & Director at Synthon Holding BV, President-Europe, Middle East & Africa at Hospira Adelaide Pty Ltd., President-Asia Pacific at Mayne Pharma Ltd., and Vice President at Hospira Australia Pty Ltd.
He also served as a Director at the Generic Medicines Industry Association Pty Ltd.
and Medicines For Europe.
Mr. Kotsanis received his undergraduate degree from Monash University and his graduate degree from the University of Technology Sydney.
Postes actifs de Michael Kotsanis
Sociétés | Poste | Début |
---|---|---|
ACRUX LIMITED | Directeur Général | 03/11/2014 |
AI Lamb (NZ) Ltd.
AI Lamb (NZ) Ltd. Pharmaceuticals: MajorHealth Technology AI Lamb (NZ) Ltd. manufactures pharmaceuticals and medicines. The private company is based in Palmerston North, New Zealand. The New Zealander company was founded in 2020 by Lisa Webster. | Directeur/Membre du Conseil | 26/11/2020 |
Anciens postes connus de Michael Kotsanis
Sociétés | Poste | Fin |
---|---|---|
IDT AUSTRALIA LIMITED | Directeur/Membre du Conseil | 28/11/2022 |
Synthon Holding BV
Synthon Holding BV Pharmaceuticals: MajorHealth Technology Synthon Holding BV engages in the research and production of therapeutic products. It offers remedies for cold sores, anaesthetic, hypertension, depression, neutralizing narcosis, insomnia, schizophrenia, heart failure and incontinence. The company was founded by Jacques Lemmens in 1991 and is headquartered in Nijmegen, Netherlands. | Directeur/Membre du Conseil | 01/10/2014 |
Hospira Adelaide Pty Ltd.
Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Corporate Officer/Principal | 01/06/2010 |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | 01/09/2006 |
Hospira Australia Pty Ltd.
Hospira Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Hospira Australia Pty Ltd. is an Australian company that manufactures and markets medication delivery systems. The company is based in Melbourne, Australia. | Corporate Officer/Principal | - |
Formation de Michael Kotsanis
Monash University | Undergraduate Degree |
University of Technology Sydney | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ACRUX LIMITED | Health Technology |
IDT AUSTRALIA LIMITED | Health Technology |
Entreprise privées | 7 |
---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Synthon Holding BV
Synthon Holding BV Pharmaceuticals: MajorHealth Technology Synthon Holding BV engages in the research and production of therapeutic products. It offers remedies for cold sores, anaesthetic, hypertension, depression, neutralizing narcosis, insomnia, schizophrenia, heart failure and incontinence. The company was founded by Jacques Lemmens in 1991 and is headquartered in Nijmegen, Netherlands. | Health Technology |
Hospira Adelaide Pty Ltd.
Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Commercial Services |
Generic Medicines Industry Association Pty Ltd.
Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Generic Medicines Industry Association Pty Ltd. operates as a representative body of generic and biosimilar medicine suppliers in Australia. The company was founded on February 23, 2001 and is headquartered in Deakin West, Australia. | Commercial Services |
Medicines For Europe | |
Hospira Australia Pty Ltd.
Hospira Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Hospira Australia Pty Ltd. is an Australian company that manufactures and markets medication delivery systems. The company is based in Melbourne, Australia. | Health Technology |
AI Lamb (NZ) Ltd.
AI Lamb (NZ) Ltd. Pharmaceuticals: MajorHealth Technology AI Lamb (NZ) Ltd. manufactures pharmaceuticals and medicines. The private company is based in Palmerston North, New Zealand. The New Zealander company was founded in 2020 by Lisa Webster. | Health Technology |